Replies to post #303907 on NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

I can chime in on this. I think it’s a $10 stock on good topline release. But I think it’s much more than that. I believe there is really no limit and if they could actually attract a partnership (which I think what this purchase announced yesterday had a lot to do with) that we’re talking about a new standard of care for all solid tumor cancers, not the adjuvant or after chemo and radiation. When you add DCVax Direct into the mix and automatization which brings the cost down and make commercialization a reality I see DCVax as the distinct leader of the industry worldwide. Is that a $60 Billion Dollar industry? A $100 Billion Dollar industry? Either way, at full realization, say in 2 years, It could be a $30 Dollar stock, a $60 Dollar stock, $100 stock?

[sentiment_stocks]

Penny Monster, I understand that you're day trading here. And that's fine, and expected, especially at times like this.

We need to know where you are at on your understanding of what this stock is before one begins to explain why we think this is a $10 stock.

For instance, let's start here.

Did you know that this company has a platform immunotherapy treatment (meaning it can expand out into more than one cancer) for solid tumor cancer, and that this treatment has been in a 15 year long randomized phase 3 trial for Glioblastoma (brain cancer - the kind John McCain died from), and that the company plans to give the top line data read out on this trial (to determine whether it worked or not) this month (September)?